ALC
LLY icon

Alexander Labrunerie & Co’s Eli Lilly LLY Stock Holding History

Alexander Labrunerie & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Sell
842
-20
-2% -$20.4K 0.35% 40
2026
Q1 		$793K Sell
862
-38
-4% -$38.5K 0.3% 51
2025
Q4 		$967K Buy
900
+4
+0.4% +$3.83K 0.35% 43
2025
Q3 		$684K Sell
896
-125
-12% -$93K 0.25% 53
2025
Q2 		$796K Buy
1,021
+11
+1% +$8.55K 0.33% 49
2025
Q1 		$834K Buy
1,010
+27
+3% +$22.5K 0.36% 47
2024
Q4 		$759K Sell
983
-28
-3% -$23.2K 0.34% 48
2024
Q3 		$896K Sell
1,011
-56
-5% -$50.3K 0.41% 42
2024
Q2 		$966K Sell
1,067
-10
-0.9% -$8K 0.52% 37
2024
Q1 		$838K Buy
+1,077
New +$766K 0.47% 38

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alexander Labrunerie & Co's LLY Position: Q2 2026 in Review

Alexander Labrunerie & Co reduced its Eli Lilly (LLY) stake by 2.3% in Q2 2026, selling an estimated $20.4K and leaving 842 shares worth $1.01M. The position accounts for 0.35% of the portfolio, ranked #40.

Alexander Labrunerie & Co first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alexander Labrunerie & Co held 842 shares of Eli Lilly worth $1.01M as of Q2 2026.
  • Alexander Labrunerie & Co sold 20 Eli Lilly shares in Q2 2026, an estimated $20.4K.
  • Eli Lilly made up 0.35% of Alexander Labrunerie & Co's portfolio in Q2 2026, its #40 holding.
  • Alexander Labrunerie & Co first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alexander Labrunerie & Co's 13F filing for Q2 2026, filed 3 Aug 2026.